首页> 外文OA文献 >Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation

【2h】

Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation

机译：改善非维生素K拮抗剂口腔抗凝血剂的创新策略在心房颤动中卒中预防

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Gregory Y H Lip; Deirdre A Lane; Tatjana S Potpara;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation [J] . Gregory Y HLip, Deirdre ALane, Tatjana SPotpara European Heart Journal: The Journal of the European Society of Cardiology . 2018,第16期

机译：改善非维生素K拮抗剂口腔抗凝血剂的创新策略在心房颤动中卒中预防
2. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group [J] . Pharithi Rebabonye B., Ranganathan Deepti, OBrien Jim, Irish journal of medical science . 2019,第1期

机译：处方是否正确？非瓣膜心房颤动患者的非维生素K拮抗剂抗凝血剂（NOAC）处方述评。心房颤动和卒中中非维生素K口腔抗凝血剂的心房颤动和评价安全规定（安全Noacs）组
3. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II) [J] . Steinberg Benjamin A., Shrader Peter, Thomas Lahie, The American heart journal . 2017,第期

机译：与新出售心房颤动患者中卒中预防相关的因素，用于预防新出售心房颤动：结果注册表的结果，用于更好地了解心房颤动II（Orbit-AF II）
4. What Is the Best Practical Scheme for Initiating Oral Anticoagulant Treatment in Outpatients with Atrial Fibrillation? [C] . R. CAZZIN, P. SERRA, C. FUSILLI International Workshop on Cardiac Arrhythmias . 2004

机译：在心房颤动的门诊患者中启动口服抗凝血治疗的最佳实用方案是什么？
5. Switching from Vitamin K Antagonists to Non-vitamin K Oral Anticoagulants, Drug-Drug Interactions, and Health Outcomes among Working-Age Adults with Atrial Fibrillation [D] . Feng, Xue. 2018

机译：从维生素K拮抗剂切换到非维生素K口服抗凝剂，药物 - 药物相互作用，以及具有心房颤动的工作年龄成年人之间的健康状况
6. Practical perspectives on the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation: A view from the Middle East and North Africa [O] . Ahmad S. Hersi, Yahya S. Alhebaishi, Omar Hamoui, 2018

机译：在非瓣膜性房颤患者中使用非维生素K拮抗剂口服抗凝剂预防中风的实践观点：来自中东和北非的观点
7. Editorial comment on ‘A novel approach indirectly comparing benefit: risk across oral antithrombotic therapies in patients with atrial fibrillation’. Are the evidences of current dose-adjusted anticoagulation with warfarin stroke prevention for patients with atrial fibrillation sufficient enough to compare with newly developed non-vitamin K oral anticoagulants? [O] . Shinichi Goto, Shinya Goto 2015

机译：编辑评论'一种小型方法间接比较益处：心房颤动患者口服抗血栓性疗法的风险'。是对充足性颤动患者的患者的当前剂量调整的抗凝，足以与新开发的非维生素K口腔抗凝剂进行比较吗？

Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation

著录项

引文网络

相似文献

相关主题

期刊订阅